A NETRF-funded study on the development of neuroendocrine tumor organoids won the best scientific poster award at the 2019 annual meeting of the European Neuroendocrine Tumor Society (ENETS) in Barcelona in March.
NETRF gave
A NETRF-funded study on the development of neuroendocrine tumor organoids won the best scientific poster award at the 2019 annual meeting of the European Neuroendocrine Tumor Society (ENETS) in Barcelona in March.
NETRF gave an Accelerator Award to Hans Clevers, MD, PhD, Hubrecht Institute, Netherlands, to develop NET organoids to expand the field’s preclinical NET research tools. An organoid is a laboratory replica of tumor cells that researchers can study to understand the nature of neuroendocrine cancer and to test new treatments.
A lead researcher involved in the project, Talya Dayton, PhD, presented their progress to date at the ENETS meeting. The Clevers lab has tried to grow 44 organoids from NET tissue samples donated for research (from tumors in small intestine, lung, and pancreas). Overall about half of the samples have grown into organoids. The lung samples have a